IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Fears on Wall Street after week of historic losses

    02:31
  • Biden visits Samsung in South Korea in plan to add 3,000 American jobs

    00:50
  • Fifth-grader with alopecia creates nonprofit to send painting kits to children’s hospitals

    01:35
  • Russia steps up attacks on Kharkiv after Ukrainian forces regain territory

    02:15
  • January 6 committee in talks with former Trump AG Bill Barr

    00:57
  • Potential monkeypox case under investigation in New York City

    01:43
  • First Buffalo mass shooting victim funeral takes place

    01:22
  • Delivery of baby formula from Europe expected this weekend as shortage worsens

    02:02
  • Judge blocks Biden administration from lifting Title 42

    02:44
  • FDA Commissioner grilled on when baby formula will return to shelves

    05:01
  • Federal Reserve faces a tough challenge on cooling inflation

    01:46
  • New exhibition at the National Gallery of Art gives viewers global journey through Black history

    01:39
  • Memorial Day vacationers hit with high travel and lodging costs

    01:33
  • Turkey opposes Sweden and Finland’s bid to join

    02:00
  • Nationwide Covid cases are up 55 percent

    01:29
  • Milk banks work to meet demand

    02:09
  • FDA Commissioner grilled on when baby formula will return to shelves

    02:51
  • Secretary of state races in the spotlight as false election theories take root in U.S.

    03:33
  • U.S. Soccer to split World Cup prize money between men’s and women’s teams

    01:38
  • Records show Hunter Biden’s company made millions from joint venture funded by Chinese company

    03:11

Exclusive: Snapchat executive on company’s efforts to stop sale of counterfeit pills

03:47

Last year, the DEA seized over 20 million counterfeit pills, some of which contained potentially lethal doses of fentanyl. Jacqueline Beauchere, Snapchat’s global head of platform safety, speaks with NBC News’ Kate Snow about what the company is doing to prevent drug-related content and activity on its platform, and hears from a parent who lost his son, who he believes connected with a dealer on the app.